News & Updates
Filter by Specialty:
Alcoholic drinks up risk of death in young adults with MASLD
Young adults with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink alcoholic beverages are at greater risk of mortality and of having an unhealthy liver, reports a study presented at AASLD 2024.
Alcoholic drinks up risk of death in young adults with MASLD
26 Nov 2024
Presence of mVI/S predicts HCC recurrence after liver resection
Microvascular invasion and/or satellitosis (mVI/S) is independently associated with aggressive recurrence and mortality in hepatocellular carcinoma (HCC) patients treated with liver resection (LR), a recent study has shown.
Presence of mVI/S predicts HCC recurrence after liver resection
26 Nov 2024
No level of alcohol intake is safe in MASLD patients, says study
Even modest alcohol consumption is associated with a higher risk of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study.
No level of alcohol intake is safe in MASLD patients, says study
25 Nov 2024
BGF inhaler safe to use in COPD patients
Treatment with budesonide/glycopyrrolate/formoterol (BGF) using a metered dose inhaler (MDI) demonstrates an acceptable safety profile and improves symptoms in patients with chronic obstructive pulmonary disease (COPD) in a real-world clinical setting, results of the TORES study have shown.
BGF inhaler safe to use in COPD patients
25 Nov 2024
Gout remission definition: Does colchicine offer an advantage?
Treatment with colchicine for 6 months when commencing urate-lowering therapy (ULT) provides no additional benefit in achieving gout remission regardless of the definition used, according to a study.
Gout remission definition: Does colchicine offer an advantage?
25 Nov 2024
Depression a costly burden for older adults with chronic diseases in Singapore
In Singapore, depression pushes up healthcare spending by twofold among older adults already struggling with chronic illnesses, according to a study.